| Entry |
|
|---|
| Name |
Felypressin (USAN/INN);
PLV-2 (TN)
|
|---|
| Formula |
C46H65N13O11S2
|
|---|
| Exact mass |
1039.4368
|
|---|
| Mol weight |
1040.2188
|
|---|
| Sequence |
Cys Phe Phe Gln Asn Cys Pro Lys Gly (Disulfide bridge: 1-6) |
|---|
| Type |
Peptide |
|---|
| Activity |
Vasoconstrictor
|
|---|
| Comment |
Component of Citanest octapressin (TN)
Vasopressin derivative
|
|---|
| Target |
arginine vasopressin receptor 1A (AVPR1A) agonist [HSA: 552] [KO: K04226] |
|---|
| Pathway |
hsa04020 Calcium signaling pathway
hsa04080 Neuroactive ligand-receptor interaction
hsa04270 Vascular smooth muscle contraction | |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Vasopressin
arginine vasopressin receptor 1A (AVPR1A) [HSA:552] [KO:K04226]
Felypressin
D04137 Felypressin (USAN/INN)
 |
|---|
| Other DBs |
CAS: 56-59-7 PubChem: DrugBank: NIKKAJI: |
|---|
